Te Ahumairangi Investment Management Ltd raised its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 4.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,297 shares of the company's stock after purchasing an additional 1,975 shares during the quarter. Procter & Gamble makes up about 1.6% of Te Ahumairangi Investment Management Ltd's holdings, making the stock its 17th biggest holding. Te Ahumairangi Investment Management Ltd's holdings in Procter & Gamble were worth $7,379,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in PG. Capital A Wealth Management LLC purchased a new position in Procter & Gamble during the 4th quarter valued at $31,000. 10Elms LLP purchased a new position in Procter & Gamble during the 4th quarter valued at $34,000. Sunbeam Capital Management LLC purchased a new position in Procter & Gamble during the 4th quarter valued at $34,000. Mizuho Securities Co. Ltd. increased its position in Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after purchasing an additional 170 shares during the period. Finally, Quest 10 Wealth Builders Inc. increased its position in Procter & Gamble by 50.3% during the 1st quarter. Quest 10 Wealth Builders Inc. now owns 245 shares of the company's stock valued at $42,000 after purchasing an additional 82 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $155.63 on Friday. The stock has a market cap of $364.54 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 4.14 and a beta of 0.37. The firm's 50-day moving average is $156.59 and its 200 day moving average is $162.63. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble's payout ratio is presently 64.98%.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on PG. Piper Sandler boosted their target price on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a report on Monday, May 5th. BNP Paribas restated an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the company a "buy" rating in a report on Wednesday, July 30th. Evercore ISI restated an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Finally, Redburn Atlantic cut shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 target price on the stock. in a report on Thursday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $175.12.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the transaction, the chief financial officer owned 52,642 shares in the company, valued at $8,279,007.34. This represents a 18.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 119,181 shares of company stock worth $18,761,172 over the last quarter. 0.18% of the stock is owned by insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.